232 related articles for article (PubMed ID: 11743941)
1. The role of neurotensin in the pathophysiology of schizophrenia and the mechanism of action of antipsychotic drugs.
Binder EB; Kinkead B; Owens MJ; Nemeroff CB
Biol Psychiatry; 2001 Dec; 50(11):856-72. PubMed ID: 11743941
[TBL] [Abstract][Full Text] [Related]
2. Enhanced neurotensin neurotransmission is involved in the clinically relevant behavioral effects of antipsychotic drugs: evidence from animal models of sensorimotor gating.
Binder EB; Kinkead B; Owens MJ; Kilts CD; Nemeroff CB
J Neurosci; 2001 Jan; 21(2):601-8. PubMed ID: 11160439
[TBL] [Abstract][Full Text] [Related]
3. Do neurotensin receptor agonists represent a novel class of antipsychotic drugs?
Cáceda R; Kinkead B; Nemeroff CB
Semin Clin Neuropsychiatry; 2003 Apr; 8(2):94-108. PubMed ID: 12728409
[TBL] [Abstract][Full Text] [Related]
4. Novel treatments of schizophrenia: targeting the neurotensin system.
Kinkead B; Nemeroff CB
CNS Neurol Disord Drug Targets; 2006 Apr; 5(2):205-18. PubMed ID: 16611093
[TBL] [Abstract][Full Text] [Related]
5. Neurotensin, schizophrenia, and antipsychotic drug action.
Kinkead B; Nemeroff CB
Int Rev Neurobiol; 2004; 59():327-49. PubMed ID: 15006494
[TBL] [Abstract][Full Text] [Related]
6. Does neurotensin mediate the effects of antipsychotic drugs?
Kinkead B; Binder EB; Nemeroff CB
Biol Psychiatry; 1999 Aug; 46(3):340-51. PubMed ID: 10435199
[TBL] [Abstract][Full Text] [Related]
7. Neurotensin-dopamine interactions: relevance to schizophrenia and the action of antipsychotic drugs.
Stowe ZN; Bissette G; Nemeroff CB
Yakubutsu Seishin Kodo; 1991 Feb; 11(1):49-59. PubMed ID: 1679273
[TBL] [Abstract][Full Text] [Related]
8. Bioactive analogs of neurotensin: focus on CNS effects.
Boules M; Fredrickson P; Richelson E
Peptides; 2006 Oct; 27(10):2523-33. PubMed ID: 16882457
[TBL] [Abstract][Full Text] [Related]
9. Chronic, but not acute, dosing of antipsychotic drugs alters neurotensin binding in rat brain regions.
Holtom PE; Needham PL; Bennett GW; Aspley S
Br J Pharmacol; 2000 Nov; 131(5):990-6. PubMed ID: 11053221
[TBL] [Abstract][Full Text] [Related]
10. Effects of acute and subchronic administration of typical and atypical antipsychotic drugs on the neurotensin system of the rat brain.
Kinkead B; Shahid S; Owens MJ; Nemeroff CB
J Pharmacol Exp Ther; 2000 Oct; 295(1):67-73. PubMed ID: 10991962
[TBL] [Abstract][Full Text] [Related]
11. Neurotensin agonists as an alternative to antipsychotics.
Boules M; Fredrickson P; Richelson E
Expert Opin Investig Drugs; 2005 Apr; 14(4):359-69. PubMed ID: 15882113
[TBL] [Abstract][Full Text] [Related]
12. The effects of typical and atypical antipsychotic drugs on neurotensin-containing neurons in the central nervous system.
Kinkead B; Nemeroff CB
J Clin Psychiatry; 1994 Sep; 55 Suppl B():30-2. PubMed ID: 7961568
[TBL] [Abstract][Full Text] [Related]
13. Expression of the proneurotensin gene in the rat brain and its regulation by antipsychotic drugs.
Merchant KM; Dobie DJ; Dorsa DM
Ann N Y Acad Sci; 1992; 668():54-69. PubMed ID: 1361120
[TBL] [Abstract][Full Text] [Related]
14. Do neuropeptide systems mediate some of the effects of antipsychotic drugs?
Bissette G; Nemeroff CB
Prog Clin Biol Res; 1985; 192():349-53. PubMed ID: 2867552
[TBL] [Abstract][Full Text] [Related]
15. Involvement of the neurotensin receptor 1 in the behavioral effects of two neurotensin agonists, NT-2 and NT69L: lack of hypothermic, antinociceptive and antipsychotic actions in receptor knockout mice.
Mechanic JA; Sutton JE; Berson AE; Wu X; Kwan J; Schreiber R; Pang Z; Button DC
Eur Neuropsychopharmacol; 2009 Jul; 19(7):466-75. PubMed ID: 19223157
[TBL] [Abstract][Full Text] [Related]
16. CSF neurotensin concentrations and antipsychotic treatment in schizophrenia and schizoaffective disorder.
Sharma RP; Janicak PG; Bissette G; Nemeroff CB
Am J Psychiatry; 1997 Jul; 154(7):1019-21. PubMed ID: 9210757
[TBL] [Abstract][Full Text] [Related]
17. Effects of haloperidol and risperidone on neurotensin levels in brain regions and neurotensin efflux in the ventral striatum of the rat.
Gruber SH; Nomikos GG; Mathé AA
Neuropsychopharmacology; 2002 May; 26(5):595-604. PubMed ID: 11927184
[TBL] [Abstract][Full Text] [Related]
18. Atypical antipsychotic drugs selectively increase neurotensin efflux in dopamine terminal regions.
Radke JM; Owens MJ; Ritchie JC; Nemeroff CB
Proc Natl Acad Sci U S A; 1998 Sep; 95(19):11462-4. PubMed ID: 9736759
[TBL] [Abstract][Full Text] [Related]
19. The neurobiology of neurotensin: focus on neurotensin-dopamine interactions.
Kasckow J; Nemeroff CB
Regul Pept; 1991 Oct; 36(2):153-64. PubMed ID: 1666685
[TBL] [Abstract][Full Text] [Related]
20. Antipsychotics and neuropeptides: the atypical profile of CI-943 and its relationship to neurotensin.
Liégeois JF; Bonaventure P; Delarge J; Damas J
Neurosci Biobehav Rev; 1995; 19(4):519-31. PubMed ID: 8684714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]